| Hodgkin Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 154show all (up to 200) |
|---|
| → investigated in trials for | Brentuximab Vedotinadc 91 trials (27 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 91 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall_molecule 87 trials (26 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 87 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 81 trials (18 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 81 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall_molecule 56 trials (22 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 56 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 55 trials (15 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal_antibody 54 trials (28 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 49 trials (21 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dacarbazinesmall_molecule 48 trials (23 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall_molecule 42 trials (17 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall_molecule 39 trials (9 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 35 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 34 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 30 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 25 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bleomycin 24 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hodgkin Lymphoma | 24 | Observed | clinicaltrials | graph → |